(medtechdive.com)—As in orthopaedic reconstruction, companies looking to move the needle in the spine device market are investing in robotics to compete.
Modest growth in the sector is a driving factor. Medtronic told investors in a session at the meeting that the U.S. spine market has returned to growth, with an increase in procedures offsetting pricing pressure. The company sees the market growing at a 2% to 3% rate, according to analyst coverage.
Medtronic’s Mazor robotics and navigation technology and a new robotics application for NuVasive’s Pulse integrated surgery platform were among the computer-assisted surgical technologies generating interest at the North American Spine Society (NASS) meeting last week in Chicago.
Also on display were Zimmer Biomet’s Rosa robot and a suite of new or pre-launch technologies from Globus Medical, according to analysts who attended the gathering.